Search by Drug Name or NDC
NDC 25021-0311-04 Furosemide 10 mg/mL Details
Furosemide 10 mg/mL
Furosemide is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is FUROSEMIDE.
MedlinePlus Drug Summary
Furosemide injection is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart failure, pulmonary edema (excess fluid in the lungs), kidney, and liver disease. Furosemide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.
Related Packages: 25021-0311-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Furosemide Injection
Product Information
| NDC | 25021-0311 |
|---|---|
| Product ID | 25021-311_222ce48f-2856-4be2-b16f-6fca38c0dceb |
| Associated GPIs | 37200030002005 |
| GCN Sequence Number | 008205 |
| GCN Sequence Number Description | furosemide VIAL 10 MG/ML INJECTION |
| HIC3 | R1M |
| HIC3 Description | LOOP DIURETICS |
| GCN | 34940 |
| HICL Sequence Number | 003660 |
| HICL Sequence Number Description | FUROSEMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Furosemide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Furosemide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | FUROSEMIDE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213902 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0311-04 (25021031104)
| NDC Package Code | 25021-311-04 |
|---|---|
| Billing NDC | 25021031104 |
| Package | 25 VIAL in 1 CARTON (25021-311-04) / 4 mL in 1 VIAL |
| Marketing Start Date | 2021-03-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.59404 |
| Pricing Unit | ML |
| Effective Date | 2023-11-22 |
| NDC Description | FUROSEMIDE 40 MG/4 ML VIAL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis